Class information for:
Level 1: LHRH RECEPTOR//AN 152//ENDOCRINE POLYPEPTIDE CANC

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
14625 692 39.9 79%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
2982 2124 ENDOCRINE POLYPEPTIDE CANC//LHRH RECEPTOR//SECT EXPT MED

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 LHRH RECEPTOR Author keyword 19 74% 2% 14
2 AN 152 Author keyword 18 89% 1% 8
3 ENDOCRINE POLYPEPTIDE CANC Address 16 26% 8% 54
4 LH RH RECEPTORS Author keyword 14 100% 1% 7
5 TARGETED CANCER CHEMOTHERAPY Author keyword 12 86% 1% 6
6 TARGETED CHEMOTHERAPY Author keyword 11 37% 4% 25
7 LH RH RECEPTOR Author keyword 9 83% 1% 5
8 GONADOTROPIN RELEASING HORMONE RECEPTOR Author keyword 7 25% 3% 23
9 AEZS 108 Author keyword 6 80% 1% 4
10 GNRH III Author keyword 6 71% 1% 5

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 LHRH RECEPTOR 19 74% 2% 14 Search LHRH+RECEPTOR Search LHRH+RECEPTOR
2 AN 152 18 89% 1% 8 Search AN+152 Search AN+152
3 LH RH RECEPTORS 14 100% 1% 7 Search LH+RH+RECEPTORS Search LH+RH+RECEPTORS
4 TARGETED CANCER CHEMOTHERAPY 12 86% 1% 6 Search TARGETED+CANCER+CHEMOTHERAPY Search TARGETED+CANCER+CHEMOTHERAPY
5 TARGETED CHEMOTHERAPY 11 37% 4% 25 Search TARGETED+CHEMOTHERAPY Search TARGETED+CHEMOTHERAPY
6 LH RH RECEPTOR 9 83% 1% 5 Search LH+RH+RECEPTOR Search LH+RH+RECEPTOR
7 GONADOTROPIN RELEASING HORMONE RECEPTOR 7 25% 3% 23 Search GONADOTROPIN+RELEASING+HORMONE+RECEPTOR Search GONADOTROPIN+RELEASING+HORMONE+RECEPTOR
8 AEZS 108 6 80% 1% 4 Search AEZS+108 Search AEZS+108
9 GNRH III 6 71% 1% 5 Search GNRH+III Search GNRH+III
10 TARGETED CHEMOTHERAPEUTIC AGENTS 6 71% 1% 5 Search TARGETED+CHEMOTHERAPEUTIC+AGENTS Search TARGETED+CHEMOTHERAPEUTIC+AGENTS

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 ANTAGONIST SB 75 53 95% 3% 18
2 500 1000 TIMES 50 88% 3% 23
3 HUMAN ENDOMETRIAL 32 48% 7% 48
4 MOUSE MAMMARY CANCERS 30 100% 2% 12
5 RESISTANCE 1 MDR 1 SYSTEM 26 100% 2% 11
6 AN 152 23 100% 1% 10
7 CYTOTOXIC ANALOG 21 78% 2% 14
8 LH RH ANALOGS 18 83% 1% 10
9 EPITHELIAL OVARIAN CARCINOMATA 18 89% 1% 8
10 GYNECOLOGICAL CANCERS 13 49% 3% 20

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Targeting of cytotoxic luteinizing hormone-releasing hormone analogs to breast, ovarian, endometrial, and prostate cancers 2005 70 79 84%
GnRH Receptors in Cancer: From Cell Biology to Novel Targeted Therapeutic Strategies 2012 16 265 45%
Gonadotropin-releasing hormone: GnRH receptor signaling in extrapituitary tissues 2008 48 145 50%
Use of Analogs of Peptide Hormones Conjugated to Cytotoxic Radicals for Chemotherapy Targeted to Receptors on Tumors 2011 22 99 52%
Gonadotropin-releasing hormone receptors as molecular therapeutic targets in prostate cancer: Current options and emerging strategies 2013 12 236 43%
Receptor-mediated tumor targeting based on peptide hormones 2010 32 87 34%
Biology of the gonadotropin-releasing hormone system in gynecological cancers 2002 108 100 49%
Human gonadotropin-releasing hormone receptor-activated cellular functions and signaling pathways in extra-pituitary tissues and cancer cells (Review) 2009 19 139 55%
THE USE OF LUTEINIZING-HORMONE-RELEASING HORMONE AGONISTS AND ANTAGONISTS IN GYNECOLOGICAL CANCERS 1994 138 80 71%
Luteinizing hormone-releasing hormone receptor targeted agents for prostate cancer 2011 10 73 56%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 ENDOCRINE POLYPEPTIDE CANC 16 26% 7.8% 54
2 SECT EXPT MED 5 18% 3.8% 26
3 ANALYT CHEM BIOPOLYMER STRUCT ANAL 4 25% 2.0% 14
4 BIOMED PHYS ENGN 3 42% 0.7% 5
5 MULTIDISCIPLINARY GYNECOL ONCOL 2 67% 0.3% 2
6 GEN HOSP OBERNDORF 1 38% 0.4% 3
7 BIOTECHNOL INCUBATING GOLDEN HELIX 1 100% 0.3% 2
8 ENDOCRINOL ONCOL 1 11% 1.4% 10
9 MED COUNCIL HUMAN REPROD SCI UNIT 1 16% 0.9% 6
10 POLYPEPTIDE CANC 1 40% 0.3% 2

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000279683 AZALINE B//ANTIOVULATORY ACTIVITY//LHRH ANTAGONISTS
2 0.0000267446 ENDOCRINE POLYPEPTIDE CANC//GHRH ANTAGONISTS//GHRH ANTAGONIST
3 0.0000172091 OVARIAN SURFACE EPITHELIUM//OVARIAN SURFACE EPITHELIUM OSE//REPROD BIOL PROGRAM
4 0.0000156055 MED OBSTET GYNECOL1150 FUKUSHIMA//D 2 DOPAMINE//HCG ALPHA
5 0.0000138140 GONADOTROPE//GNRH RECEPTOR//FUNCT GENOM S
6 0.0000120576 TERMINAL NERVE//NERVUS TERMINALIS//GONADOTROPIN RELEASING HORMONE
7 0.0000119465 EXPLORATORY DISCOVERY//CYCLIC IMINES//3 ACYLLACTAMS
8 0.0000079594 LIVINGSTON REPROD BIOL//HLTH SCI GYNECOL OBSTET//LUTEINIZATION STIMULATOR
9 0.0000079176 THIMET OLIGOPEPTIDASE//EP2415//NEUROLYSIN
10 0.0000075993 ESTROGENIC RECRUITMENT//AMINOGLUTETHIMIDE//CYCLIC TREATMENT